Literature DB >> 8318804

Effect of growth hormone treatment on craniofacial growth in Turner's syndrome.

C Rongen-Westerlaken1, E vd Born, B Prahl-Andersen, A von Teunenbroek, P Manesse, B J Otten, I vd Tweel, A M Kuijpers-Jagtman, H A Delemarre vd Waal, N M Drayer.   

Abstract

A cephalometric study was performed in 19 patients with Turner's syndrome, aged 8.7-16.5 years. A lateral roentgen-encephalogram was taken before and after two years of treatment with biosynthetic growth hormone in a dose of 24 IU/m2/week. During two years of growth hormone treatment, the mandibular length increased mainly due to vertical growth. The initially posteriorly rotated mandible showed an anterior rotation, although the normal position was not reached. The other linear measurements and angles did not change during treatment. No indications were found for an increase in the disproportionate growth or for excessive chin growth as a sign of acromegaly during growth hormone treatment. In conclusion, growth hormone treatment in patients with Turner's syndrome resulted in an increase in mandibular length, mainly due to vertical growth of the ramus and in the anterior rotation of the mandible.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8318804     DOI: 10.1111/j.1651-2227.1993.tb12698.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  3 in total

Review 1.  Craniofacial morphology and dental maturity in children with reduced somatic growth of different aetiology and the effect of growth hormone treatment.

Authors:  Sotiria Davidopoulou; Athina Chatzigianni
Journal:  Prog Orthod       Date:  2017-04-27       Impact factor: 2.750

2.  Developmental Abnormalities of the Skull Base in Patients with Turner Syndrome.

Authors:  Adina-Ioana Tecuta-Busoi; Marius Matei; Lucian Mihai Florescu; Ioana Andreea Gheonea
Journal:  Curr Health Sci J       Date:  2020-12-31

3.  Craniofacial and dentoalveolar morphology in individuals with Prader-Willi syndrome: a case-control study.

Authors:  Gisela Vasconcelos; Jo S Stenehjem; Stefan Axelsson; Ronnaug Saeves
Journal:  Orphanet J Rare Dis       Date:  2022-02-22       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.